| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 42 | 2024 | 865 | 6.970 |
Why?
|
| Genome, Human | 42 | 2025 | 1267 | 6.000 |
Why?
|
| Genomic Structural Variation | 20 | 2024 | 79 | 5.580 |
Why?
|
| Genomics | 35 | 2025 | 1477 | 4.990 |
Why?
|
| Sequence Analysis, DNA | 46 | 2024 | 1760 | 4.920 |
Why?
|
| Software | 21 | 2024 | 677 | 4.740 |
Why?
|
| Haplotypes | 13 | 2024 | 519 | 2.160 |
Why?
|
| Computational Biology | 9 | 2024 | 800 | 1.980 |
Why?
|
| Polymorphism, Single Nucleotide | 17 | 2024 | 2599 | 1.860 |
Why?
|
| Genetic Variation | 18 | 2025 | 1480 | 1.640 |
Why?
|
| DNA Copy Number Variations | 13 | 2025 | 940 | 1.600 |
Why?
|
| DNA Methylation | 7 | 2024 | 991 | 1.570 |
Why?
|
| Genome | 12 | 2024 | 472 | 1.430 |
Why?
|
| Algorithms | 6 | 2022 | 1597 | 1.130 |
Why?
|
| Alleles | 7 | 2024 | 1607 | 1.120 |
Why?
|
| Nanopores | 8 | 2022 | 11 | 1.120 |
Why?
|
| Benchmarking | 9 | 2025 | 132 | 1.120 |
Why?
|
| Polymorphism, Genetic | 2 | 2023 | 810 | 1.010 |
Why?
|
| Chromosome Mapping | 7 | 2023 | 1083 | 0.960 |
Why?
|
| Hominidae | 1 | 2024 | 27 | 0.950 |
Why?
|
| Metagenomics | 2 | 2024 | 109 | 0.910 |
Why?
|
| Lipoprotein(a) | 1 | 2024 | 113 | 0.880 |
Why?
|
| Population Health | 1 | 2024 | 35 | 0.870 |
Why?
|
| Metagenome | 1 | 2024 | 148 | 0.840 |
Why?
|
| Mosaicism | 2 | 2024 | 240 | 0.820 |
Why?
|
| Humans | 89 | 2025 | 123181 | 0.790 |
Why?
|
| Cryptosporidium | 1 | 2022 | 32 | 0.790 |
Why?
|
| Hybridization, Genetic | 3 | 2019 | 20 | 0.790 |
Why?
|
| INDEL Mutation | 7 | 2024 | 88 | 0.780 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 27 | 0.780 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 41 | 0.780 |
Why?
|
| Industrial Development | 1 | 2021 | 2 | 0.760 |
Why?
|
| Germ Cells | 2 | 2024 | 192 | 0.760 |
Why?
|
| DNA Transposable Elements | 3 | 2021 | 177 | 0.720 |
Why?
|
| Perciformes | 2 | 2017 | 6 | 0.700 |
Why?
|
| Transcriptome | 5 | 2024 | 909 | 0.700 |
Why?
|
| Microbiota | 1 | 2024 | 392 | 0.640 |
Why?
|
| Genotype | 7 | 2023 | 2548 | 0.610 |
Why?
|
| Arabidopsis | 4 | 2019 | 69 | 0.570 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 793 | 0.550 |
Why?
|
| Sequence Alignment | 3 | 2015 | 623 | 0.530 |
Why?
|
| Whole Genome Sequencing | 9 | 2024 | 286 | 0.510 |
Why?
|
| Genome, Plant | 6 | 2020 | 23 | 0.480 |
Why?
|
| Base Sequence | 9 | 2023 | 3093 | 0.480 |
Why?
|
| Chromosomes, Human, Y | 2 | 2025 | 46 | 0.460 |
Why?
|
| Genetics, Population | 4 | 2024 | 189 | 0.440 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 1650 | 0.420 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1684 | 0.400 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 1861 | 0.400 |
Why?
|
| Glucosylceramidase | 3 | 2022 | 27 | 0.400 |
Why?
|
| Gene Frequency | 3 | 2022 | 715 | 0.390 |
Why?
|
| Phenotype | 8 | 2025 | 4225 | 0.380 |
Why?
|
| Parkinson Disease | 3 | 2023 | 669 | 0.370 |
Why?
|
| Diploidy | 3 | 2020 | 35 | 0.360 |
Why?
|
| Animals | 22 | 2025 | 33732 | 0.360 |
Why?
|
| DNA, Circular | 2 | 2020 | 18 | 0.350 |
Why?
|
| Exome | 3 | 2023 | 1041 | 0.310 |
Why?
|
| Chromosome Inversion | 3 | 2024 | 76 | 0.310 |
Why?
|
| Chromosomes, Human | 4 | 2022 | 132 | 0.310 |
Why?
|
| Brain | 4 | 2024 | 2947 | 0.310 |
Why?
|
| Quantitative Trait Loci | 4 | 2023 | 283 | 0.300 |
Why?
|
| Schizosaccharomyces | 2 | 2019 | 65 | 0.300 |
Why?
|
| Genotyping Techniques | 4 | 2021 | 101 | 0.300 |
Why?
|
| Circadian Clocks | 2 | 2019 | 59 | 0.280 |
Why?
|
| Gene Duplication | 4 | 2024 | 358 | 0.280 |
Why?
|
| Tandem Repeat Sequences | 2 | 2024 | 36 | 0.280 |
Why?
|
| Evolution, Molecular | 4 | 2019 | 672 | 0.280 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2022 | 475 | 0.280 |
Why?
|
| Genome, Fungal | 2 | 2017 | 31 | 0.280 |
Why?
|
| Mutation | 6 | 2024 | 5777 | 0.270 |
Why?
|
| Genetic Testing | 3 | 2023 | 997 | 0.270 |
Why?
|
| Gene Rearrangement | 4 | 2024 | 326 | 0.270 |
Why?
|
| Genome, Viral | 3 | 2021 | 171 | 0.260 |
Why?
|
| Human Genome Project | 2 | 2024 | 55 | 0.260 |
Why?
|
| Lymphoma | 2 | 2021 | 322 | 0.250 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2025 | 3098 | 0.250 |
Why?
|
| Cell Line | 4 | 2024 | 2779 | 0.240 |
Why?
|
| Neoplasms | 4 | 2024 | 2767 | 0.240 |
Why?
|
| Epistasis, Genetic | 3 | 2020 | 91 | 0.240 |
Why?
|
| Sequence Analysis | 2 | 2023 | 54 | 0.240 |
Why?
|
| Pitheciidae | 1 | 2024 | 1 | 0.230 |
Why?
|
| Major Histocompatibility Complex | 2 | 2023 | 51 | 0.230 |
Why?
|
| DNA | 4 | 2022 | 1592 | 0.230 |
Why?
|
| Chromosomes, Human, X | 1 | 2025 | 157 | 0.230 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 2483 | 0.220 |
Why?
|
| RNA Editing | 2 | 2014 | 33 | 0.220 |
Why?
|
| Adenosine Deaminase | 2 | 2014 | 74 | 0.220 |
Why?
|
| Blood Cells | 1 | 2022 | 50 | 0.210 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2020 | 48 | 0.210 |
Why?
|
| Lewy Body Disease | 1 | 2022 | 18 | 0.200 |
Why?
|
| Chromosomes, Mammalian | 1 | 2022 | 41 | 0.200 |
Why?
|
| Mesocricetus | 1 | 2022 | 71 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 515 | 0.200 |
Why?
|
| Machine Learning | 1 | 2024 | 220 | 0.200 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2024 | 306 | 0.200 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 73 | 0.200 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 267 | 0.190 |
Why?
|
| Macaca mulatta | 1 | 2023 | 493 | 0.190 |
Why?
|
| Bias | 1 | 2021 | 125 | 0.190 |
Why?
|
| Genomic Instability | 1 | 2022 | 229 | 0.190 |
Why?
|
| Reproductive Isolation | 2 | 2019 | 4 | 0.180 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2023 | 154 | 0.180 |
Why?
|
| Songbirds | 1 | 2020 | 7 | 0.180 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 15 | 0.180 |
Why?
|
| Medical Oncology | 1 | 2021 | 213 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 214 | 0.170 |
Why?
|
| Forensic Genetics | 1 | 2020 | 10 | 0.170 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2021 | 199 | 0.170 |
Why?
|
| Polychondritis, Relapsing | 1 | 2019 | 5 | 0.170 |
Why?
|
| Workflow | 1 | 2020 | 114 | 0.170 |
Why?
|
| Microcephaly | 1 | 2023 | 328 | 0.170 |
Why?
|
| Genome, Mitochondrial | 1 | 2019 | 31 | 0.170 |
Why?
|
| Domestication | 1 | 2019 | 2 | 0.170 |
Why?
|
| Annelida | 1 | 2019 | 1 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 278 | 0.160 |
Why?
|
| Gaucher Disease | 1 | 2019 | 12 | 0.160 |
Why?
|
| Precision Medicine | 1 | 2022 | 313 | 0.160 |
Why?
|
| Sexual Maturation | 1 | 2019 | 48 | 0.160 |
Why?
|
| Abnormalities, Multiple | 2 | 2022 | 965 | 0.160 |
Why?
|
| Arthritis | 1 | 2019 | 81 | 0.160 |
Why?
|
| Deafness | 1 | 2019 | 81 | 0.160 |
Why?
|
| Fishes | 1 | 2019 | 41 | 0.160 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 314 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 478 | 0.150 |
Why?
|
| Gene Amplification | 1 | 2018 | 228 | 0.150 |
Why?
|
| Oncogenes | 1 | 2018 | 169 | 0.150 |
Why?
|
| Phylogeny | 4 | 2023 | 685 | 0.140 |
Why?
|
| RNA-Binding Proteins | 3 | 2022 | 573 | 0.140 |
Why?
|
| Introduced Species | 1 | 2017 | 22 | 0.140 |
Why?
|
| Chromatin | 1 | 2020 | 552 | 0.140 |
Why?
|
| Proteome | 1 | 2019 | 233 | 0.140 |
Why?
|
| Heterozygote | 4 | 2022 | 672 | 0.140 |
Why?
|
| Chironomidae | 1 | 2016 | 1 | 0.140 |
Why?
|
| Tidal Waves | 1 | 2016 | 1 | 0.140 |
Why?
|
| Acclimatization | 1 | 2016 | 15 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2019 | 371 | 0.140 |
Why?
|
| Bass | 1 | 2016 | 2 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2019 | 637 | 0.130 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2017 | 109 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2014 | 831 | 0.130 |
Why?
|
| Exons | 1 | 2019 | 795 | 0.130 |
Why?
|
| Genome, Insect | 1 | 2016 | 95 | 0.130 |
Why?
|
| Critical Care | 1 | 2022 | 650 | 0.130 |
Why?
|
| Biological Evolution | 1 | 2017 | 221 | 0.130 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 2851 | 0.130 |
Why?
|
| Ananas | 1 | 2015 | 1 | 0.130 |
Why?
|
| Photosynthesis | 1 | 2015 | 10 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 448 | 0.130 |
Why?
|
| Leukemia Virus, Feline | 1 | 2015 | 5 | 0.130 |
Why?
|
| Retroviridae Infections | 1 | 2015 | 10 | 0.120 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 804 | 0.120 |
Why?
|
| Proteomics | 1 | 2019 | 480 | 0.120 |
Why?
|
| Cat Diseases | 1 | 2015 | 14 | 0.120 |
Why?
|
| Candida albicans | 1 | 2015 | 76 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1043 | 0.120 |
Why?
|
| Reference Standards | 3 | 2023 | 241 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 121 | 0.120 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 313 | 0.120 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 269 | 0.120 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 133 | 0.120 |
Why?
|
| Candidiasis | 1 | 2015 | 129 | 0.120 |
Why?
|
| Tumor Virus Infections | 1 | 2015 | 134 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2019 | 847 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 261 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2015 | 610 | 0.110 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2012 | 9 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 353 | 0.110 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2024 | 65 | 0.100 |
Why?
|
| Sulfites | 1 | 2012 | 30 | 0.100 |
Why?
|
| Nucleotides | 2 | 2022 | 92 | 0.100 |
Why?
|
| Clonal Evolution | 2 | 2023 | 38 | 0.100 |
Why?
|
| Mutagenesis | 1 | 2012 | 347 | 0.100 |
Why?
|
| Telomere | 2 | 2023 | 208 | 0.100 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2024 | 574 | 0.090 |
Why?
|
| Male | 11 | 2025 | 60018 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 796 | 0.090 |
Why?
|
| Plant Breeding | 2 | 2020 | 13 | 0.090 |
Why?
|
| Female | 12 | 2025 | 65426 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 2 | 2020 | 144 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 452 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 3287 | 0.080 |
Why?
|
| HLA Antigens | 2 | 2021 | 243 | 0.080 |
Why?
|
| Databases, Genetic | 2 | 2024 | 471 | 0.080 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 222 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2024 | 1338 | 0.080 |
Why?
|
| Pedigree | 2 | 2023 | 1582 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 996 | 0.070 |
Why?
|
| RNA, Viral | 2 | 2021 | 540 | 0.070 |
Why?
|
| Reproduction | 2 | 2019 | 243 | 0.060 |
Why?
|
| Neanderthals | 1 | 2025 | 1 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2024 | 71 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2024 | 54 | 0.060 |
Why?
|
| China | 1 | 2025 | 241 | 0.060 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 123 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 2048 | 0.060 |
Why?
|
| DNA, Satellite | 1 | 2023 | 18 | 0.060 |
Why?
|
| Heterochromatin | 1 | 2023 | 48 | 0.060 |
Why?
|
| Cisplatin | 1 | 2025 | 242 | 0.060 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2023 | 81 | 0.050 |
Why?
|
| Virus Integration | 1 | 2023 | 42 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 26 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 227 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 63 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 22 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 42 | 0.050 |
Why?
|
| Multigene Family | 1 | 2023 | 298 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2023 | 137 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2023 | 175 | 0.050 |
Why?
|
| Models, Animal | 1 | 2024 | 465 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2022 | 93 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 83 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2021 | 21 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 115 | 0.050 |
Why?
|
| Leukemia, B-Cell | 1 | 2021 | 26 | 0.050 |
Why?
|
| DNA Fingerprinting | 1 | 2021 | 108 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2023 | 185 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 244 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2022 | 311 | 0.050 |
Why?
|
| New York City | 1 | 2021 | 59 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2021 | 219 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2021 | 212 | 0.050 |
Why?
|
| Ecotype | 1 | 2020 | 4 | 0.040 |
Why?
|
| Mice | 4 | 2025 | 17492 | 0.040 |
Why?
|
| Inbreeding | 1 | 2020 | 8 | 0.040 |
Why?
|
| Reference Values | 1 | 2022 | 696 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 184 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 463 | 0.040 |
Why?
|
| Haploidy | 1 | 2020 | 19 | 0.040 |
Why?
|
| Retroelements | 1 | 2020 | 41 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 577 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 334 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 302 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2020 | 71 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 135 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2021 | 254 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2022 | 139 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 189 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 121 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 149 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 355 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 481 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 300 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 210 | 0.040 |
Why?
|
| Flowers | 1 | 2019 | 7 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 382 | 0.040 |
Why?
|
| CpG Islands | 1 | 2020 | 321 | 0.040 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2020 | 136 | 0.040 |
Why?
|
| Plants, Genetically Modified | 1 | 2019 | 42 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2023 | 8089 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 80 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1387 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2019 | 53 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 252 | 0.040 |
Why?
|
| Fruit | 1 | 2020 | 221 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2020 | 196 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 211 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2020 | 338 | 0.040 |
Why?
|
| Chromosome Duplication | 1 | 2019 | 147 | 0.040 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 105 | 0.040 |
Why?
|
| Organoids | 1 | 2020 | 276 | 0.040 |
Why?
|
| Genome Size | 1 | 2017 | 15 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 13862 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2018 | 367 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2019 | 441 | 0.040 |
Why?
|
| Chromosomes, Fungal | 1 | 2017 | 49 | 0.030 |
Why?
|
| Moon | 1 | 2016 | 12 | 0.030 |
Why?
|
| DNA, Plant | 1 | 2016 | 10 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 793 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 343 | 0.030 |
Why?
|
| Basidiomycota | 1 | 2016 | 11 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 28 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2017 | 54 | 0.030 |
Why?
|
| Gene Editing | 1 | 2019 | 187 | 0.030 |
Why?
|
| Vitis | 1 | 2016 | 14 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 309 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2016 | 75 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 1121 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 251 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 549 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 767 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 740 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2016 | 168 | 0.030 |
Why?
|
| DNA Repair | 1 | 2019 | 582 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 3716 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 4708 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 312 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 239 | 0.030 |
Why?
|
| Cats | 1 | 2015 | 117 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 259 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 495 | 0.030 |
Why?
|
| Epigenomics | 1 | 2015 | 162 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2017 | 351 | 0.030 |
Why?
|
| Internet | 1 | 2017 | 378 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 346 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 757 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 326 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 76 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 1875 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3050 | 0.030 |
Why?
|
| Adolescent | 2 | 2022 | 19086 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2024 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 19068 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1105 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 762 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1677 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 2577 | 0.030 |
Why?
|
| Cytosine | 1 | 2012 | 56 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1294 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 740 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1586 | 0.020 |
Why?
|
| Middle Aged | 2 | 2022 | 25976 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 738 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 1695 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 256 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2012 | 209 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 527 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1292 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3260 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7124 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4508 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 12323 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 4351 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6201 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2820 | 0.020 |
Why?
|
| Child | 1 | 2024 | 24208 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 29035 | 0.010 |
Why?
|